⌕
Ardent Health · ARDT · NYSE
Tenet 55 · Mixed
Compare
$17.80+0.68%At closeTenet 55 · Mixed
$17.80+0.12 (+0.68%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD

Ardent Health (ARDT) Earnings Forecast

Analysts expect Ardent Health (ARDT) to earn $1.05 a share in FY26, the average of 6 estimates as of Nov 13, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice
FY26 consensus EPS
$1.05
6 analysts
FY27 consensus EPS
$1.24
6 analysts · low $1.18, high $1.32
EPS revisions, 30 days
+9.6%
$0.95 to $1.05
Disagreement, FY26
4.8%
high to low, $1.03 to $1.08

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 13, 2026 · we check it nightly

Analysts expect Ardent Health to earn $1.30 a share in FY28, growing about 12% a year; 6 analysts publish an estimate for FY28.

Forward P/E · FY26E
17.0×
$17.80 (as of close, Nov 13, 2026) ÷ $1.05 consensus EPS
Coverage · FY26
6 · 8
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $1.05, up 2.6% in 91 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 91 days. One step per nightly change.

−9.9%−0.9%+8.0%FY27 +5.7%FY26 +2.6%Aug 15Nov 13
EPS30 days90 daysshown aboveSince Jul 6
FY266 analysts▲ +9.6%$0.95 to $1.05▲ +2.6%$1.02 to $1.05▼ −6.7%$1.12 to $1.05
FY276 analysts▲ +6.3%$1.16 to $1.24▲ +5.7%$1.17 to $1.24▼ −3.0%$1.28 to $1.24
Sep '264 analysts▼ −1.5%$0.24 to $0.23▲ +2.6%$0.23 to $0.23▼ −6.3%$0.25 to $0.23
Dec '265 analysts▲ +5.5%$0.33 to $0.35▲ +4.4%$0.34 to $0.35▲ +4.4%$0.34 to $0.35

Contributors at both ends of the window: FY26 5 and 6. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 13, 2026 · consensus as of Nov 13, 2026

At 17.3 times earnings, which is what Ardent Health trades at today, the FY27 consensus of $1.24 works out to $21 a share.

Consensus EPS · FY27
$1.24
6 analysts · low $1.18, high $1.32 · thin coverage
Multiple · today's trailing P/E
17.3×
$17.80 (as of close, Nov 13, 2026) ÷ $1.03, the last four reported quarters, including EPS computed by Tenet
×
Receipt · ARDT · FY27Nov 13, 2026
Implied, a share
$21

Range on the low and high estimate: $20 to $23.

$20 low$23 high
1.24 × 17.3, to the dollar
Drag the multipleShaded: where Ardent Health's P/E sat at each fiscal year end, FY24 to FY25. Each dot is one year.
8×10×12×14×16×18×19×
5-yr avg 10.0×10-yr median 10.0×today 17.3×$21 a share

Each point on the line is a multiple, and the flag is the price it implies for FY27. Past multiples are context, not a guide to future ones.

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

You are paying 17.0 times the FY26 consensus for earnings the Street expects to grow about 12% a year to FY28. That is 1.5 times the growth rate.Show today's multiple against its own recordHide the multiple record
Trailing P/E at each fiscal year end, FY24 to FY25 · over 2 fiscal years. The mark is the median of the last 2.
17.3× today
9.2× low10.8× high
10.0× median
Forward 17.0× is a different measure, so it is not placed on a trailing record. Today's mark is the trailing 17.3×, on the same basis as every year behind it.

How much do analysts disagree?

For FY28, estimates run from $1.03 to $1.56 around an average of $1.30, drawn by 6 analysts.

FY26E6 analysts
$1.03 to $1.08 · 4.8%
FY27E6 analysts
$1.18 to $1.32 · 11.6%
FY28E6 analysts
$1.03 to $1.56 · 40.6%

The dashed line is FY25 filed $0.96, on the GAAP basis.

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.

Is next quarter a high bar or an easy one?

Analysts expect Ardent Health to earn $0.35 a share in the December quarter, the average of 5 estimates. Results are expected by Feb 10, 2027. Last quarter, which ended in September, Ardent Health earned $0.31 a share. Analysts had expected $0.23, so it came in 33.6% higher.

$0.32
$0.35high $0.37
low $0.34
+10.3%crosses bases
Dec 2025 quarterfiled · GAAPDec 2026 quarterconsensus · Street basis · 5 analysts
Expected report
Feb 10, 2027
Expected by Feb 10. An estimate, not a date the company has set. Companies move it.
Revenue expected · December quarter
$1,638.1M
7 analysts, 1,613.7 to 1,648.0 in $M · 1,605.1 in the same quarter a year ago

The step from a filed quarter to a consensus crosses bases: the filed figure is the company's own GAAP number and the consensus is on the Street's basis. It is printed with both bases named, not as growth. For the March quarter, analysts expect $0.29 a share.

Does Ardent Health usually beat or miss?

So far we have checked 7 quarters, of which 7 came in above the estimate we held. We add a quarter to this record each time Ardent Health reports. The next report is expected by Feb 10, 2027.

We started recording estimates on Jul 6, 2026, so quarters that reported before that date cannot be checked.

Before our record
Sep '23
Mar '24
Our record, one quarter per report
+10.8%
Jun '24reaction
+6.1%
Sep '24left out · adjusted
+76.4%
Dec '24reaction
−12.5%
+44.3%
Mar '25reaction
+9.2%
+129.9%
Jun '25reaction
+6.1%
Sep '25left out · adjusted
+1.0%
Dec '25reaction
−2.1%
+46.7%
Mar '26reaction
−7.5%
Jun '26left out · adjusted
+33.6%
Sep '26reaction
+22.4%
reportsFeb 10
Dec '26
Mar '27
Checked so far
7 quarters
one more every report
Beat expectations
7 of 7
full details on the Earnings tab
Share price reaction
+3.1%
the average over all 7 checked quarters, one session each, timed to each release
Typical gap vs estimate
+44.3%
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for Ardent Health on Jul 6, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact. Jun '24, Dec '24, Mar '25, Jun '25, Dec '25, Mar '26 are drawn hollow: we hold no estimate for those quarters recorded strictly before the report, so it is scored against the last estimate we hold rather than the night-before one.

The Street expects sales to grow 3.2% in FY27 and EPS 18.3%. Little of it is sales: the net margin moves from 2.3% to 2.6%, and the implied share count from about 142M to 143M, so these numbers assume no buyback.Show the decomposition and the margin ladderHide the decomposition
FY27 EPS growth, in points
Revenue growth+3.2
Net margin change+15.7
Share count change−0.6
EPS growth+18.3
Legs are rounded to a tenth of a point and the largest remainder carries the difference, so they add to the total. Implied shares = consensus net income ÷ consensus EPS, a direction rather than a decimal.
6 analysts publish an EPS estimate for FY26 and 8 publish revenue. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
86
FY26E
96
FY27E
66
FY28E
The FY26 panel held 5 analysts when our record of it began on Jul 6, 2026 and holds 6 tonight.

The full consensus, year by year

Consensus as of Nov 13, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
5.06.17.2historyStreet forecastFY22FY25FY28E

Coverage thins with distance: 8 revenue estimates for FY26, 6 for FY28.

Diluted EPS · $filed · consensus average · band = low to high
0.360.991.63historyStreet forecastFY22FY25FY28E

Out-year bands widen as fewer analysts publish: 6 EPS estimates for FY26, 6 for FY28.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed6.3—0.96————as filed17.3×
FY26E6.56.5 to 6.5▲2.5%a1.051.03 to 1.08▲9.0%a0.40.10.148 · 617.0×
FY27E6.76.6 to 6.7▲3.2%1.241.18 to 1.32▲18.3%0.50.20.149 · 614.4×
FY28E7.06.8 to 7.1▲4.1%1.301.03 to 1.56▲5.1%0.50.20.156 · 613.7×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 6 EPS estimates for FY26, 8 for revenue. Not investment advice.

What do analysts expect Ardent Health to earn in FY26?

Analysts expect Ardent Health to earn $1.05 a share in FY26, the average of 6 estimates as of Nov 13, 2026.

What is Ardent Health's earnings forecast for FY27?

The FY27 consensus for Ardent Health is $1.24 a share from 6 analysts, with a low of $1.18 and a high of $1.32, as of Nov 13, 2026.

Have analysts raised Ardent Health's earnings estimates?

Ardent Health's FY26 EPS consensus rose 2.6% in 91 days, from $1.02 to $1.05, as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.